Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus

Annals of Nutrition and Metabolism

Volumn 44, Issue 2, 2000, Pages 54-60

  Levy, Yishai ^a,c   Zaltsberg, Haya ^a   Ben Amotz, Ami ^b   Kanter, Yoram ^a   Aviram, Michael ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b NATIONAL INSTITUTE OF OCEANOGRAPHY   (Israel)

^c HaEmck Medical Center   (Israel)

Author keywords

Atherosclerosis; Beta carotene; Diabetes mellitus; Lipid peroxidation; Lipoproteins

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; BETA CAROTENE; CAROTENOID; CHOLESTEROL; COPPER SULFATE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; RETINOL; SATURATED FATTY ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; ISOMER; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHOLIPID BLOOD LEVEL; PLANT; PRIORITY JOURNAL; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

DUNALIELLA BARDAWIL;

EID: 0033818983     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012821     Document Type: Article

References (37)

1. Kanncll WB, Hjorlland M, Castelli WP: Role of diabetes in cardiac disease: Conclusions from population studies. The Framingham Study. Am J Cardiol 1974;34:29-34.
2. Steiner G: Atherosclerosis, the major complication of diabetes. Adv Exp Med Biol 1985; 189: 277-297.
3. Morel DW, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotcin oxidation and cytotoxicity. J Lipid Res 1989;30: 1827-1834.
4. Nishigaki I, Hagihara M, Tsunckawa H, Maseki M, Yagi K: Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981;25:373-378.
5. Lyons TJ: Glycation and oxidation: A role in pathogenesis of atherosclerosis (review). Am J Cardiol 1995;7:23B-31B.
6. Baynes J\V: Role of oxidative stress in development of complications in diabetes. Diabetes 1991:40:405-412.
7. Hunt JV, Bottoms MA, Mitchinson MJ: Ascorbic acid oxidation: A potential cause of the elevated severity of atherosclerosis in diabetes mellitus? FEBS 1992;311:161-164.
8. Buring JE, Hcnnekens CH: Antioxidants and coronary heart disease: Weighing the totality of the evidence. J Cardiovasc Risk 1996;3:343-345.
9. Krinsky NI: Antioxidant functions of carotenoids. Free Radie Biol Med 1989;7:617-635.
10. Lavy A, Bcn-Amotz A, Aviram M: Preferential inhibition of LDL oxidation by the all-trans isomer of -β-carotene in comparison to the 9-cis-β-carotene. Eur J Clin Chcm Clin Biochem 1993:31:83-90.
11. Levy Y, Ben-Amotz A, Aviram M: Effect of dietary supplementation of different β-carotene isomcrs on lipoprotein oxidative modification. J Nutr Med 1995;5:13-22.
12. Ben-Amotz A, Levy Y: Unavailability of a natural isomer mixture compared with synthetic all-trans β-carotene in human scrum. Am J Clin Nutr 1996;63:729-734.
13. Ben-Amotz A, Edelstein S, Avron M: Use of the carotene-rich alga Diinaliclla bardamlas a source of retinol. Br Poultry Sei 1986;27:613-619.
14. Aviram M: Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoprotcinemic patients. Biochem Med 1983;30:111-118.
15. Morel DW: Lipid peroxidation assay for thiobarbituric acid reactive substances. Arteriosclerosis 1984;4:357-364.
16. El-Saadani M, Estcrbaucr H, El-Sayed M, Goher M, Nassar AY, Jürgens G: A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989:30:627-630.
17. Estcrbaucr H, Stricgl G, Puhl H, Rothcncder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radie Res Commun 1989;6:67-75.
18. Fuhrman B, Lavy A, Aviram M: Consumption of red wine w ith meals reduces the susceptibility of human plasma and low-density lipoprotein to undergo lipid peroxidation. Am J Clin Nutr 1995:61:549-554.
19. Lowry OH, Roscbrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chcm 1951;193:265-275.
20. Moss C\V, Dees SB, Gurront GO: Gas liquid chromatography of bacterial fatty acids with a fused silica capillary column. J Clin Microbiol 1980:12:127-130.
21. Rabini RA, Fumclli P, Galassi R, Doussct N, Taus M, Fcrrctti G, Mazzanti L, Curatola G, Solera ML, Valdigulc P: Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism 1994;43:1470-1474.
22. Fuller CJ, Chandalia M, Garg A, Grundy SM, Jialal I: RRR-a-tocophcryl acetate supplementation at pharmacologie doses decreases lowdcnsity-lipoprotein oxidativc susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutr 1996;63:753-759.
23. Reaven PD, Herald DA, Barnctt J, Edelman S: Effect of vitamin E on susceptibility of LDL and LDL subfractions to oxidation and on protein glycosylation in NIDDM. Diabetes Care 1995; 18:807-816.
24. Babiy AV, Gebicki JM, Sullivan DR, Willcy K: Increased o.xidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharma 1992;43:995-1000.
25. Bagdade JD, Lane JT, Subbaiah PV, Otto ME, Ritter MC: Accelerated cholestcryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis I993;104:69-77.
26. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR: Persistent abnormalities in lipoprotein composition in non-insulin-depcndent diabetes after intensive insulin therapy. Arteriosclerosis 1990;10:232-239.
27. Verma SP, Philippot JR, Bonnet B, RostainCapaillon D, Sainte-Marie J, Colette C, Monier L: Structural abnormality in LDL from diabetic patients as revealed by resonance roman spectroscopy. Diabetes 1990;39:1451-1456.
28. Dimitriadis E, Griffin M, Collins P, Johnson A, Owens D, Tomkin GH: Lipoprotein composition in NIDDM: The effects of dietary oleic acid on the composition oxidizability and function of low and hieh density lipoproteins. Diabetologia l996;39:667-676.
29. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tonikin GH: Oxidation of low density lipoprotcin in non-insulin-dcpcndcnt diabetes, its relationship to fatty acid composition. Diabctologia 1995;38:1300-1306.
30. Maxwell SRJ, Thomason H, Sandier D, Lcgucn C, Baxter MA, Thorpc GH, Jones AF, Barnctt AH: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependcnt diabetes mellitus. Eur J Clin Invest I997;27:484-490.
31. Salonen JT, Nyyssonen K, Tuomaincn TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Heimrich SP, Salonen R: Increased risk of noninsulin dependent diabetes mellitus at low plasma vitamin E concentrations: A four-year follow-up study in men. BMJ 1995;331:11241127.
32. Stahl W, Schwarz W, Sies H: Human serum concentration of all-trans β-carotcne and acarotcnc but not 9-cis β-carotene increase upon ingestion of a natural isomer mixture obtained from Dunaliella satina (Betatcne). J Nutr 1993; 123:847-851.
33. Bitterman N, Melamed Y, Ben-Amotz A: βCarotene and CNS oxygen toxicity in rats. J Appl Physiol 1994;76:1073-1076.
34. Levin G, Mokady S: Antioxidant activity of 9cis compared to all-trans β-carotene in vitro. Free Radie Biol Med 1994; 17:77-82.
35. Levy Y, Kaplan M, Bcn-Amotz A, Aviram M: The effect of dietary supplementation of pcarotcnc on human monocyte-macrophagcmcdiatcd oxidation of low density lipoprotcin. IsrJMedSciI996;32:473-478.
36. Johnson JE, Krinsky NI, Russell RM: Serum response of all-trans and 9-cis isomers of βcarotene in humans. J Am Coll Nutr 1996; 15: 620-624.
37. Fuhrman B, Elis A, Aviram M: Hypocholcsterolemic effect of lycopcne and β-carotcnc is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 1997;233:658-662.